Catalog No. |
TD-VK623056 |
Species reactivity |
Zaire ebolavirus (ZEBOV) |
Applications |
Research Grade Biosimilar |
Host species |
Human |
Isotype |
IgG1, kappa |
Expression system |
Mammalian Cells |
Clonality |
Monoclonal |
Target |
Envelope glycoprotein, GP1,2, GP, Shed GP, GP1,2-delta, GP1, GP2, GP |
Endotoxin level |
Please contact the lab for this information. |
Purity |
>95% purity as determined by SDS-PAGE. |
Purification |
Protein A/G, purified from cell culture supernatant. |
Accession |
Q05320 |
Form |
Liquid |
Storage buffer |
0.01M PBS,pH7.4. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
Alternate Names |
REGN-3470-3471-3479,REGN-3470/REGN-3471/REGN-3479,INMAZEB™(odesivimab-ebgn,maftivimab,andatoltivimab),CAS:2135632-36-7 |
Background |
Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection. |
Note |
For research use only. Not for use in clinical or therapeutic applications. |